clonidine hydrochloride · Tris Pharma Inc · NDA 217645
Onyda Xr
Earliest generic entry, as listed
28 Jul 2041
Blocked by patent: US 11918689, US 12576032.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11918689 | drug product, use U-3944 · sets the listed date | 28 Jul 2041 |
| US 12576032 | use U-2357 · sets the listed date | 28 Jul 2041 |
| US 8062667 | drug product | 29 Mar 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 217645 · 001 · RLD | suspension, extended release, oral | 0.1MG/ML | 28 Jul 2041 |